drugset / Trial / NCT03393403

Comparison of the Effect of Intravenous and Perineural Dexmedetomidine in Gastric Cancer Surgery

NCT03393403 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

Using random case assignment to investigate the analgesic and sedative effect of intravenous dexmedetomidine and dexmedetomidine as a local anesthetic adjuvant in ultrasound-guided subcostal TAP block in gastric cancer patient undergoing gastrectomy or partial gastrectomy.

Timeline

Start
2017-12-23
Primary completion
2020-12-31
Completion
2020-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous

Indications